Reliance Global Group, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Reliance Global Group, Inc. (the "Company") on June 30, 2023. The filing discloses the entry into a Confidential Settlement Agreement and Mutual Release regarding ongoing legal disputes involving the Company's subsidiary, Medigap Healthcare Insurance Agency, LLC.
Key Financial Metrics
The filing does not provide standard financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity for the reporting period. The primary financial disclosure is a one-time settlement payment.
- Settlement Payment Received: $2,900,000
- Payment Date: July 6, 2023
- Source of Funds: Medigap Parties (including Pagidem, LLC, Joseph J. Bilotti, III, Kyle Perrin, and the Lewis Parties)
Material Changes and Legal Resolutions
The Company resolved three significant legal matters collectively known as the "Medigap Disputes" through the Settlement Agreement:
- Bilotti Arbitration: Claims against the Bilotti Parties for fraudulent inducement, breach of contract, and civil theft.
- Perrin Arbitration: Claims against former executive Kyle Perrin for conversion, fraud, and breach of fiduciary duty, including counterclaims by Mr. Perrin.
- Lewis Litigation: Claims against the Lewis Parties for tortious interference and breach of contract.
Upon receipt of the $2,900,000 payment, all parties agreed to dismiss these proceedings with prejudice and release each other from past, existing, and future claims related to these matters. The filing notes that claims against a separate entity, the "Factor" (United Insurance Group Agency, Inc. and/or LTC Global, Inc.), are explicitly excluded from this release and remain disputed.
Outlook, Risks, and Contingencies
The filing indicates that the parties continue to dispute the underlying allegations despite the settlement. A material contingency remains regarding the debt alleged by the "Factor," which the Reliance Parties dispute. The settlement effectively terminates the Asset Purchase Agreement, Employment Agreement, and Non-Disclosure Agreement associated with the Medigap acquisition.
Investor Verification Checklist
- Verify the impact of the $2,900,000 settlement payment on the Company's cash position and net income in the subsequent quarterly report.
- Confirm the status of the disputed debt claims from the "Factor" (United Insurance Group Agency, Inc./LTC Global, Inc.) which were not resolved in this agreement.
- Review the attached Exhibit 10.1 for specific terms regarding the mutual release and any non-disclosure provisions.
- Monitor future filings for any updates on the dismissed arbitrations and litigation to ensure no further legal costs arise.